Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in Recurrent Malignant Gliomas
NCT00004204Phase 2Unknown
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Feb 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in malignant glioma, sponsored by Herbert Irving Comprehensive Cancer Center. Status: unknown.
02
Drugs
temozolomide
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00004204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004204.